MedTrace Logo

Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy

NCT01185132 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 660

Last updated 2014-06-26

No results posted yet for this study

Summary

In the setting of radiotherapy as part of breast-conservation therapy for patients with early stage breast cancer, the novel planning and delivery method of intensity modulated radiotherapy is an effective and safe alternative to the commonly-used standard 3D-conformal external beam radiotherapy, spares more normal breast and lung tissue, and may lead to improved clinical outcomes.

Conditions

Interventions

RADIATION

accelerated partial breast irradiation - 3D-conformal planning

38.5 Gy, 10 fractions over 5 days

RADIATION

accelerated partial breast irradiation - IMRT planning

38.5 Gy, 10 fractions over 5 days

Sponsors & Collaborators

  • Rocky Mountain Cancer Centers

    lead OTHER

Principal Investigators

  • Charles Leonard, MD · Rocky Mountain Cancer Centers

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2018-07-31
Completion
2028-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01185132 on ClinicalTrials.gov